A study evaluating effect of Sacubitril/Valsartan on endogenous intact (active) GLP-1 compared to valsartan in patients with type 2 diabetes or pre-diabetes and elevated blood pressure.

At a glance
Trial Overview
Trial Details
- Other Details
- Related Drugs
Interventions
Trial History
References

Trial Profile

A study evaluating effect of Sacubitril/Valsartan on endogenous intact (active) GLP-1 compared to valsartan in patients with type 2 diabetes or pre-diabetes and elevated blood pressure.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sacubitril/valsartan (Primary) ; Valsartan
Indications Hypertension; Prediabetic state; Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

23 Apr 2018 New trial record
20 Mar 2018 Enrollment will begin in late 2017.
20 Mar 2018 Trial design presented at The 100th Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com